Portage Biotech Inc.

NASDAQ: PRTG · Real-Time Price · USD
8.55
-0.25 (-2.84%)
At close: Aug 15, 2025, 3:59 PM
8.57
0.23%
After-hours: Aug 15, 2025, 07:52 PM EDT

Portage Biotech Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Net Income
-67.28M -71.08M -75.35M -144.91M -113.04M -108.97M -104.67M -19.07M -15.78M -17.57M -19.17M -21.8M -18.78M -18.36M -15.83M -6.22M -6.76M -6.01M
Depreciation & Amortization
43K 51K 54K 108.62M 108.6M 108.59M 108.58M 1K -81K -38K -363K -363K -282K -325K n/a 265K 265K 265K
Stock-Based Compensation
1.41M 2.01M 2.64M 2.91M 3.39M 3.87M 4.28M 6.32M 7.22M 8.14M 9.14M 14.55M 12.64M 10.73M 8.85M 1.1M 1.36M 1.7M
Other Working Capital
-157.73K 463.08K 964.08K -611.53K 532.81K -92K 21K 702K -41K -55K -833K 267K 199K -686K -633K -1.32M -1.26M -233K
Other Non-Cash Items
65.02M 65.41M 67.76M 43.07M -1.12M -1.27M -2.37M 372.99K -230.01K -216.01K -275.01K -294.8K -110.92K 137.07K -235.93K 203.87K 639K 236K
Deferred Income Tax
-9.41M -10.33M -10.48M -25.43M -13.84M -15.48M -17.88M 1.91M -175K 1.72M 4.39M 2.11M 2.02M 2.67M 2.55M 451K 451K 451K
Change in Working Capital
326.08K 1.3M 982.08K -121.64K 877K -96K -10K 864K 483K 638K -461K 368K -110K -95K 323K -67K -17K -66K
Operating Cash Flow
-9.89M -12.63M -14.4M -15.86M -15.14M -13.35M -12.07M -9.61M -8.57M -7.33M -6.73M -5.43M -4.63M -5.24M -4.34M -4.27M -4.07M -3.42M
Capital Expenditures
n/a n/a n/a -43.5 32.11 -2.93K -2.93K -2.89K -2.97K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1M -1M -1M -1M
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -11.27K -11.27K -11.27K -11.27K n/a n/a n/a
Sales Maturities Of Investments
2.81M 2.81M 2.81M n/a n/a n/a n/a n/a n/a n/a n/a 1.58K 1.58K 1.58K 1.58K n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -8.9K 6.57K -600.66K -600.66K -591.76K -607.23K n/a n/a n/a n/a 140K 140K 140K 140K n/a
Investing Cash Flow
2.81M 2.81M 2.81M -8.95K 6.61K -603.6K -603.6K -594.65K -610.2K n/a n/a -9.7K -9.7K 130.31K -869.7K -860K -860K -1M
Debt Repayment
-42K -42K -40K -28K -17K -2.01M -2M -2M -2M n/a n/a 50K 50K 50K 50K n/a -200K -200K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
56.4K 55.4K 35.4K 5.26M -110K -1.12M -1.1M -1.03M -1.01M -81K -1.75M -1.75M -1.75M -3.82M -2.4M -1.4M -1.4M 652K
Financial Cash Flow
5.35M 5.4M 6.02M 8.09M 3.54M 489K -117K -2.3M -2.94M -11.27K 27.42M 27.52M 27.4M 25.46M 4.76M 5.71M 5.51M 7.43M
Net Cash Flow
-1.68M -4.36M -5.52M -7.76M -11.59M -13.48M -12.81M -12.5M -12.22M -7.44M 20.58M 21.97M 22.83M 20.42M -382K 643K 587K 3.01M
Free Cash Flow
-9.79M -12.53M -14.3M -15.77M -15.14M -13.35M -12.08M -9.65M -8.6M -7.36M -6.76M -5.43M -4.57M -5.18M -4.28M -4.21M -4.07M -3.42M